Demystifying the Evolving Science and Potential Role of Incretins in T2D

QDCE_small-700x200

In this episode, Kristin Gusack, RD will interview Bernhard Ludvik, MD and Thomas Forst, MD.  They will discuss the practical application of data and frequently asked questions from the independent satellite symposium, Demystifying the Evolving Science and Potential Role of Incretins in T2D, presented at IDF World Diabetes Congress on December 6, 2022.

Or just listen to the episode using the player below:
Scroll to Top